vVARDIS, a dental technology company specializing in non-invasive caries treatment, has secured a minority strategic investment from Apollo Funds. This funding will fuel vVARDIS's global growth and commercial expansion, including further development of its Curodont™ product line. The article does not specify the investment amount or any client, revenue, pipeline, or employee count metrics.
